Storia in 2 fonti

Divi’s Labs hits 52-week high as analysts pile in after healthy Q1

The stock has now gained over 25 per cent in the past month alone and 33 per cent year-to-date, significantly outperforming the Nifty Next 50 index, of which it is a constituent.

Raccontata da

economictimes.indiatimes.com

thehindubusinessline.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

thehindubusinessline.comStai leggendo4 g fa

Divi’s Labs hits 52-week high as analysts pile in after healthy Q1

The stock has now gained over 25 per cent in the past month alone and 33 per cent year-to-date, significantly outperforming the Nifty Next 50 index, of which it is a constituent.

originale

economictimes.indiatimes.com6 g fa

Divi's Labs Q1 Results: Net profit rises 66% YoY to Rs 902 crore, revenue up 28%

Divi's Labs reported Q1 profit Rs 902 crore (+66% YoY), revenue Rs 3,080 crore (+28% YoY), PBT Rs 1,180 crore. Export-heavy pharma player scaling profitably despite forex headwinds—signals operational leverage and potential healthcare tech consolidation M&A readiness.

Timeline cronologica

sabato 1 agosto 2026·economictimes.indiatimes.com
Divi's Labs Q1 Results: Net profit rises 66% YoY to Rs 902 crore, revenue up 28%
The firms revenue from operations meanwhile rose around 28% YoY to Rs 3,080 crore in Q1 FY27, from Rs 2,410 crore reported in the year-ago period. Its total income increased over…
lunedì 3 agosto 2026·thehindubusinessline.com
Divi’s Labs hits 52-week high as analysts pile in after healthy Q1
The stock has now gained over 25 per cent in the past month alone and 33 per cent year-to-date, significantly outperforming the Nifty Next 50 index, of which it is a constituent.